Sanofi invests in AI enterprise

Sunday 21 November 2021


Sanofi SA has announced an equity investment of $180 million in Owkin, a company with an AI platform which enables scientists to conduct research on diseases without having to pool data centrally. The model, called ‘federated learning,’ enables data scientists to securely connect to decentralised, multi-party data sets and create AI models for targeted drug discovery. Owkin is based in New York City, US but has scientific roots in France.